AI eases East Africa’s cross-border payments but not costs

AI eases East Africa’s cross-border payments but not costs

Like many industries across the globe, artificial intelligence (AI) has taken the financial industry by storm, and one of the fast-rising applications is in payments, to solve age-old challenges that have slowed cross-border settlements in the banking sector.

In East Africa, banks have not been left behind in the latest revolution as nearly all have now deployed AI to improve their cross-border payment to local and international customers.

Jeremy Awori, who heads the Lome-headquartered lender Ecobank Group, says regional financiers are already using AI mostly to combat fraud in payments, boost customer experience, and enhance efficiency and speed of settlements.

“AI engines are studying transaction patterns,” he told The EastAfrican. “And those can be used to help produce better customer experience, and to detect anomalies, hence minimise fraud or theft.”

Ecobank CEO Jeremy Awori at the Africa Financial Industry Summit in Casablanca, Morocco on December 9, 2024.

Photo credit: Vincent Owino | Nation Media Group

Thanks to AI, banks can now tell how frequent a Kenyan, for example, does business with a Tanzanian, and from that, recommend different products that could further facilitate their trade. It could also tell if someone makes frequent foreign trips, and recommend travel insurance, for example.

The machine learning tools can also tell if certain payments seem like ones you’d normally make or not, and stop any suspicious ones, limiting fraudulent activities, without the need for human intervention.

A new global study released this week by consultancy KPMG shows that the world over, AI is increasingly gaining traction in the financial industry.

The sector is the fastest adopter of the new technology, with at least 29 percent of polled firms already at advanced levels of using the systems.

Companies in the sector are mostly using AI for financial planning, accounting, and risk management, but there is also extensive use in treasury management, tax operations, and reporting, the survey found.

Yet, in the region, the near-magical technology cannot solve one of the oldest and most-pressing challenges in cross-border payments – cost. Currently, payment corridors in East Africa are some of the costliest across the globe.

A Tanzanian paying for goods or services in Uganda, for instance, would have to part with about 50 percent of the amount as transaction fees, and still wait for hours for the settlement to be completed.

Original Media Source

Share this news

Facebook
Twitter
LinkedIn
WhatsApp

This Year's Most Read News Stories

Tanzania Confirms Outbreak of Marburg Virus Disease
Tanzania Foreign Investment News
Chief Editor

Tanzania Confirms Outbreak of Marburg Virus Disease

Dodoma — Tanzania today confirmed an outbreak of Marburg virus disease in the northwestern Kagera region after one case tested positive for the virus following investigations and laboratory analysis of suspected cases of the disease.

President of the Republic of Tanzania, Her Excellency Samia Suluhu Hassan, made the announcement during a press briefing alongside World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, in the country’s administrative capital Dodoma.

“Laboratory tests conducted in Kabaile Mobile Laboratory in Kagera and later confirmed in Dar es Salaam identified one patient as being infected with the Marburg virus. Fortunately, the remaining suspected patients tested negative,” the president said. “We have demonstrated in the past our ability to contain a similar outbreak and are determined to do the same this time around.”

A total of 25 suspected cases have been reported as of 20 January 2025, all of whom have tested negative and are currently under close follow-up, the president said. The cases have been reported in Biharamulo and Muleba districts in Kagera.

“We have resolved to reassure the general public in Tanzania and the international community as a whole of our collective determination to address the global health challenges, including the Marburg virus disease,” said H.E President Hassan.

WHO is supporting Tanzanian health authorities to enhance key outbreak control measures including disease surveillance, testing, treatment, infection prevention and control, case management, as well as increasing public awareness among communities to prevent further spread of the virus.

“WHO, working with its partners, is committed to supporting the government of Tanzania to bring the outbreak under control as soon as possible, and to build a healthier, safer, fairer future for all the people of Tanzania,” said Dr Tedros. “Now is a time for collaboration, and commitment, to protecting the health of all people in Tanzania, and the region, from the risks posed by this disease.”

Marburg virus disease is highly virulent and causes haemorrhagic fever. It belongs to the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly. Patients present with high fever, severe headache and severe malaise. They may develop severe haemorrhagic symptoms within seven days.

“The declaration by the president and the measures being taken by the government are crucial in addressing the threat of this disease at the local and national levels as well as preventing potential cross-border spread,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Our priority is to support the government to rapidly scale up measures to effectively respond to this outbreak and safeguard the health of the population,”

Tanzania previously reported an outbreak of Marburg in March 2023 – the country’s first – in Kagera region, in which a total of nine cases (eight confirmed and one probable) and six deaths were reported, with a case fatality ratio of 67%.

In the African region, previous outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Ghana, Kenya, Equatorial Guinea, Rwanda, South Africa and Uganda.

Marburg virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials. Although several promising candidate medical countermeasures are currently undergoing clinical trials, there is no licensed treatment or vaccine for effective management or prevention of Marburg virus disease. However, early access to treatment and supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improve survival.

Source: allafrica.com

Continue Reading